BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17680888)

  • 1. Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice.
    Ji J; McDermott JL; Dluzen DE
    J Neuroendocrinol; 2007 Sep; 19(9):725-31. PubMed ID: 17680888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in dopamine- and vesicular monoamine-transporter functions.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in reserpine-induced striatal dopamine output and content between female and male mice: implications for sex differences in vesicular monoamine transporter 2 function.
    Dluzen DE; Bhatt S; McDermott JL
    Neuroscience; 2008 Jul; 154(4):1488-96. PubMed ID: 18515015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone modulation of striatal dopamine output in orchidectomized mice.
    Shemisa K; Kunnathur V; Liu B; Salvaterra TJ; Dluzen DE
    Synapse; 2006 Oct; 60(5):347-53. PubMed ID: 16838357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine.
    Kunnathur V; Shemisa K; Liu B; Salvaterra TJ; Dluzen DE
    Neurotoxicol Teratol; 2006; 28(5):557-62. PubMed ID: 16978834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC; Dluzen DE
    Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion increases striatal vesicular monoamine transport.
    Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems.
    Ji J; Bourque M; Di Paolo T; Dluzen DE
    Biochem Pharmacol; 2009 Dec; 78(11):1401-11. PubMed ID: 19615345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.
    Dluzen DE; Salvaterra TJ
    Neuroendocrinology; 2005; 82(2):78-86. PubMed ID: 16415598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-related differences in striatal dopaminergic system after traumatic brain injury.
    Xu X; Cao S; Chao H; Liu Y; Ji J
    Brain Res Bull; 2016 Jun; 124():214-21. PubMed ID: 27210290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter function differences between male and female CD-1 mice.
    Bhatt SD; Dluzen DE
    Brain Res; 2005 Feb; 1035(2):188-95. PubMed ID: 15722058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL; Darvesh AS
    Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine output is compromised within +/- BDNF mice.
    Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM
    Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits.
    Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1181-7. PubMed ID: 12604695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice.
    Lewis C; Dluzen DE
    Neurosci Lett; 2008 Dec; 448(1):130-3. PubMed ID: 18852023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M; Liu B; Dluzen DE; Di Paolo T
    Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging and sex differences in striatal dopaminergic function.
    McDermott JL; Dluzen DE
    Neuroscience; 2007 Oct; 149(2):401-8. PubMed ID: 17900817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry.
    Volz TJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2006 Jul; 155(1):109-15. PubMed ID: 16480775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.
    Truong JG; Wilkins DG; Baudys J; Crouch DJ; Johnson-Davis KL; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1087-92. PubMed ID: 15901804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomifensine alters sex differences in striatal dopaminergic function.
    Poth LS; O'Connell BP; McDermott JL; Dluzen DE
    Synapse; 2012 Aug; 66(8):686-93. PubMed ID: 22389194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.